Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain

  • Bura, S. Andreea, 1978-
  • Guegan, Thomas, 1983-
  • Zamamillo Castanedo, Daniel
  • Vela Hernández, José Miguel
  • Maldonado, Rafael, 1961-
BACKGROUND: The treatment of neuropathic pain is unsatisfactory at the present moment and the sigma 1 receptor has been identified as a new potential target for neuropathic pain. The aim of this study was to use an operant self-administration model to reveal the potential interest of a new sigma 1 receptor antagonist, S1RA, in chronic pain that was developed in mice by a partial ligation of the sciatic nerve. METHODS: Once that chronic pain had reached a steady state, mice were trained to maintain an operant behaviour to self-administer S1RA. The possible abuse liability of the analgesic compound was determined by evaluating operant self-administration in sham-operated mice. The influence of S1RA on the anhedonic state related to chronic pain was also evaluated by measuring the preference for palatable drink (2% sucrose solution) using a recently validated and highly sensitive behavioural device. RESULTS: Nerve-injured mice, but not sham-operated animals, acquired the operant responding to obtain S1RA (6 mg/kg/infusion). After 10 days of S1RA self-administration, neuropathic pain was significantly reduced in nerve-injured mice. In addition, an anhedonic state was revealed in nerve-injured mice by a decreased consumption of palatable drink, which was significantly attenuated by S1RA (25 mg/kg). CONCLUSIONS: These results reveal the analgesic efficacy of the sigma antagonist, S1RA, in neuropathic pain associated with an improvement of the emotional negative state and that was devoided of reinforcing effects. The operant responses evaluated in this new mouse model can have a high predictive value to estimate the clinical benefit/risk ratio of new analgesic compounds to treat chronic pain, such as S1RA., S1RA was provided by Esteve as a gift within research projects funded by the CENIT program (CEN-20061005) from the Centro para el Desarollo Technológico Industrial from the Spanish Ministry of Science and Innovation (#SAF2007-64062), “Redes temáticas de investigación cooperativa en salud (RETICS) del Instituto de Salud Carlos III (RD06/001/001). Red de trastornos adictivos (RTA)”, the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008) and the DG Research of the European Commission (PHECOMP, #LSHM-CT-2007-037669)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate

  • La Porta, Carmen, 1985-
  • Bura, S. Andreea, 1978-
  • Aracil Fernández, Auxiliadora
  • Manzanares, Jorge
  • Maldonado, Rafael, 1961-
Joint pain is a common clinical problem for which both inflammatory and degenerative joint diseases are major causes. The purpose of this study was to investigate the role of CB1 and CB2 cannabinoid receptors in the behavioral, histological, and neurochemical alterations associated with joint pain. The murine model of monosodium iodoacetate (MIA) was used to induce joint pain in knockout mice for CB1 (CB1KO) and CB2 cannabinoid receptors (CB2KO) and transgenic mice overexpressing CB2 receptors (CB2xP). In addition, we evaluated the changes induced by MIA in gene expression of CB1 and CB2 cannabinoid receptors and μ-, δ- and κ-opioid receptors in the lumbar spinal cord of these mice. Wild-type mice, as well as CB1KO, CB2KO, and CB2xP mice, developed mechanical allodynia in the ipsilateral paw after MIA intra-articular injection. CB1KO and CB2KO demonstrated similar levels of mechanical allodynia of that observed in wild-type mice in the ipsilateral paw, whereas allodynia was significantly attenuated in CB2xP. Interestingly, CB2KO displayed a contralateral mirror image of pain developing mechanical allodynia also in the contralateral paw. All mouse lines developed similar histological changes after MIA intra-articular injection. Nevertheless, MIA intra-articular injection produced specific changes in the expression of cannabinoid and opioid receptor genes in lumbar spinal cord sections that were further modulated by the genetic alteration of the cannabinoid receptor system. These results revealed that CB2 receptor plays a predominant role in the control of joint pain manifestations and is involved in the adaptive changes induced in the opioid system under this pain state., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062), “Instituto de Salud Carlos III” (RETICS- Red de Trastornos Adictivos-Redes Temáticas de Investigación Cooperativa en Salud: #RD06/0001/0001, #RD06/0001/1004), Plan Nacional sobre Drogas (PNSD #2009/026), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT, # LSHM-CT-2004-05166, and PHECOMP, # LSHM-CT-2007-037669), CENIT program (CEN-20061005) from/nthe “Centro para el Desarollo Technológico Industrial” from the Spanish Ministry of Science and Innovation. Carmen La Porta (C.L.P) is a recipient of a predoctoral fellowship from the Spanish Ministry of Education. Auxiliadora Aracil-Fernández (A.A.F., predoctoral fellow) and Analía Rico (A.R., technician) are supported by RETICS. The partial support of FEDER funds (EU) is also acknowledged
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour

  • Orejarena Serrano, María-Juliana, 1980-
  • Lanfumey, Laurence
  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing properties. Current evidence indicates that serotonin 5-HT2A receptors (5-HT2ARs) modulate mesolimbic dopamine (DA) activity and several behavioural responses related to the addictive properties of psychostimulants. This study evaluated the role of 5-HT2ARs in MDMA-induced reinforcement and hyperlocomotion, and the reinstatement of MDMA-seeking behaviour. Basal and MDMA-stimulated extracellular levels of DA in the nucleus accumbens (NAc) and serotonin and noradrenaline in the prefrontal cortex were also assessed. Self-administration of MDMA was blunted in 5-HT2AR knockout (KO) mice compared to wild-type (WT) littermates at both doses tested (0.125 and 0.25 mg/kg per infusion). Horizontal locomotion was increased by MDMA (10 and 20 mg/kg i.p.) to a higher extent in KO than in WT mice. DA outflow in the NAc was lower in KO compared to WT mice under basal conditions and after MDMA (20 mg/kg) challenge. In WT mice, MDMA (5 and 10 mg/kg i.p.) priming did not reinstate MDMA-seeking behaviour, while cue-induced reinstatement was prominent. This cue-induced reinstatement was blocked by administration of the selective 5-HT2AR antagonist, SR46349B (eplivanserin) at a dose of 0.5 mg/kg, but not at 0.25 mg/kg. Our results indicate that 5-HT2ARs are crucial for MDMA-induced reinforcement and cue-induced reinstatement of MDMA-seeking behaviour. These effects are probably due to the modulation of mesolimbic dopaminergic activity., This work was supported by the Instituto de Salud Carlos III FIS grant no. PI070709 (to P.R.) and Red de trastornos adictivos (RTA-RETICS) grant no. RD06/001/001 (to R.M.), the Ministerio de Ciencia e Innovación grant no. SAF2007-64062 (to R.M.), the Generalitat de Catalunya grant no. 2009SGR00731 and ICREA Academia award (to R.M.) and the European Commission projects GENADDICT (no. LSHM-CT-2004-05166) and PHECOMP (no. LSHM-CT-037669) (both to R.M.)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies ERK activity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Gangarossa, Giuseppe
  • Santini, Emanuela
  • Fisone, Gilberto
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Food palatability produces behavioral modifications that resemble those induced by drugs of abuse. Palatability-induced behavioral changes require both, the activation of the endogenous cannabinoid system, and changes in structural plasticity in neurons of the brain reward pathway. The ERK intracellular pathway is activated by CB1 receptors (CB1-R) and plays a crucial role in neuroplasticity. We investigated the activation of the ERK signaling cascade in the mesocorticolimbic system induced by operant training to obtain highly palatable isocaloric food and the involvement of the CB1-R in these responses. Using immunofluorescence techniques, we analyzed changes in ERK intracellular pathway activation in the mesocorticolimbic system of wild-type and CB1 knockout mice (CB1-/-) trained on an operant paradigm to obtain standard, highly caloric or highly palatable isocaloric food. Operant training for highly palatable isocaloric food, but not for standard or highly caloric food, produced a robust activation of the ERK signaling cascade in the same brain areas where this training modified structural plasticity. These changes induced by the operant training were absent in CB1-/-. We can conclude that the activation of the ERK pathway is associated to the neuroplasticity induced by operant training for highly palatable isocaloric food and might be involved in CB1-R mediated alterations in behavior and structural plasticity., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062 and #SAF2008-00962), “Instituto de Salud Carlos III” (#RD06/001/001), “Plan Nacional sobre Drogas, the Catalan Government” (SGR2009-00131 and SGR 2009-224), the “ICREA Foundation” (ICREA Academia-2008), the “DG Research of the European Commission” (GENADDICT, #LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the “FIS” (PI07/0715), “ATIP-Avenir” and “Sanofi-Aventis” grants. This work was also supported by the “Plan Nacional Sobre Drogas” (#2009/026) to R.M
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Ayuso, Eduard
  • Santini, Emanuela
  • Fisone, Gilberto
  • Bosch, Fatima
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Palatability enhances food intake by hedonic mechanisms that prevail over caloric necessities. Different studies have demonstrated the role of endogenous cannabinoids in the mesocorticolimbic system in controlling food hedonic value and consumption. We hypothesize that the endogenous cannabinoid system could also be involved in the development of food-induced behavioral alterations, such as food-seeking and binge-eating, by a mechanism that requires neuroplastic changes in the brain reward pathway. For this purpose, we evaluated the role of the CB1 cannabinoid receptor (CB1-R) in the behavioral and neuroplastic changes induced by operant training for standard, highly caloric or highly palatable isocaloric food using different genetics, viral and pharmacological approaches. Neuroplasticity was evaluated by measuring changes in dendritic spine density in neurons previously labeled with the dye DiI. Only operant training to obtain highly palatable isocaloric food induced neuroplastic changes in neurons of the nucleus accumbens shell and prefrontal cortex that were associated to changes in food-seeking behavior. These behavioral and neuroplastic modifications induced by highly palatable isocaloric food were dependent on the activity of the CB1-R. Neuroplastic changes induced by highly palatable isocaloric food are similar to those produced by some drugs of abuse and may be crucial in the alteration of food-seeking behavior leading to overweight and obesity., This work was supported by the Spanish Ministerio de Ciencia e Innovació (#SAF2007-64062 and #SAF2008-00962), the Instituto de Salud CarlosIII (#RD06/001/001), the Plan Nacional sobre Drogas, the Catalan Government (SGR2009-00131 and SGR2009-224), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT,/n#LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the FIS’’ (PI07/0715),ATIP-Avenir and Sanofi-Aventis grants.This work was also supported by the Plan Nacional Sobre Drogas (#2009/026) to R.M.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Operant model of frustrated expected reward in mice

  • Burokas, Aurelijus, 1982-
  • Gutiérrez Cuesta, Javier
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
One aspect of the addictive process that has not been thoroughly investigated is the consequence of the frustrated state occurring when the drug is not available. The present study aimed to validate a novel operant model of frustrated expected reward in mice. C57BL/6J mice were trained in operant conditioning maintained by chocolate-flavoured pellets or cocaine. After the completion of high rates of responding on a progressive ratio schedule, the reward was unexpectedly withheld. The consequences of this frustrated behaviour on anxiety, aggressiveness, perseveration, extinction and reinstatement were investigated. Mice exposed to the frustrated event perseverated in the operant responses and showed increased aggressiveness in the resident-intruder test. These animals also showed higher rates of cue-induced reinstatement of drug seeking. The present study provides a reliable operant model in mice to evaluate a frustrated state following reward unavailability. This animal model could be useful to study the behavioural and neurochemical consequences related to the emotional states generated during the omission of a highly expected reward., This work was supported by the DG Research of the European Commission (PHECOMP, no. LHSM-CT-2007—037669 and GENADDICT, no. LSHM-CT-2004—05166), the Spanish ‘Instituto de Salud Carlos III’ (RTA, no. RD06/001/001), the Spanish ‘Ministerio de Ciencia e Innovación’ (no. SAF2007-64062), the Spanish ‘Ministerio de Sanidad, Política Social e Igualdad’ (Plan/nNacional Sobre Drogas, no. 2009/026), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008). A.B. was supported by an FI pre-doctoral fellowship of the Catalan Government; J.G.-C. was supported by a ‘Juan de la Cierva’ postdoctoral fellowship from the Spanish ‘Ministerio de Ciencia e Innovación’; and E.M.-G. was supported by a ‘Sara Borrell’ post-doctoral fellowship from the Spanish ‘Instituto de Salud Carlos III’. Partial support from FEDER funds is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies ERK activity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Gangarossa, Giuseppe
  • Santini, Emanuela
  • Fisone, Gilberto
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Food palatability produces behavioral modifications that resemble those induced by drugs of abuse. Palatability-induced behavioral changes require both, the activation of the endogenous cannabinoid system, and changes in structural plasticity in neurons of the brain reward pathway. The ERK intracellular pathway is activated by CB1 receptors (CB1-R) and plays a crucial role in neuroplasticity. We investigated the activation of the ERK signaling cascade in the mesocorticolimbic system induced by operant training to obtain highly palatable isocaloric food and the involvement of the CB1-R in these responses. Using immunofluorescence techniques, we analyzed changes in ERK intracellular pathway activation in the mesocorticolimbic system of wild-type and CB1 knockout mice (CB1-/-) trained on an operant paradigm to obtain standard, highly caloric or highly palatable isocaloric food. Operant training for highly palatable isocaloric food, but not for standard or highly caloric food, produced a robust activation of the ERK signaling cascade in the same brain areas where this training modified structural plasticity. These changes induced by the operant training were absent in CB1-/-. We can conclude that the activation of the ERK pathway is associated to the neuroplasticity induced by operant training for highly palatable isocaloric food and might be involved in CB1-R mediated alterations in behavior and structural plasticity., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062 and #SAF2008-00962), “Instituto de Salud Carlos III” (#RD06/001/001), “Plan Nacional sobre Drogas, the Catalan Government” (SGR2009-00131 and SGR 2009-224), the “ICREA Foundation” (ICREA Academia-2008), the “DG Research of the European Commission” (GENADDICT, #LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the “FIS” (PI07/0715), “ATIP-Avenir” and “Sanofi-Aventis” grants. This work was also supported by the “Plan Nacional Sobre Drogas” (#2009/026) to R.M
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Operant model of frustrated expected reward in mice

  • Burokas, Aurelijus, 1982-
  • Gutiérrez Cuesta, Javier
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
One aspect of the addictive process that has not been thoroughly investigated is the consequence of the frustrated state occurring when the drug is not available. The present study aimed to validate a novel operant model of frustrated expected reward in mice. C57BL/6J mice were trained in operant conditioning maintained by chocolate-flavoured pellets or cocaine. After the completion of high rates of responding on a progressive ratio schedule, the reward was unexpectedly withheld. The consequences of this frustrated behaviour on anxiety, aggressiveness, perseveration, extinction and reinstatement were investigated. Mice exposed to the frustrated event perseverated in the operant responses and showed increased aggressiveness in the resident-intruder test. These animals also showed higher rates of cue-induced reinstatement of drug seeking. The present study provides a reliable operant model in mice to evaluate a frustrated state following reward unavailability. This animal model could be useful to study the behavioural and neurochemical consequences related to the emotional states generated during the omission of a highly expected reward., This work was supported by the DG Research of the European Commission (PHECOMP, no. LHSM-CT-2007—037669 and GENADDICT, no. LSHM-CT-2004—05166), the Spanish ‘Instituto de Salud Carlos III’ (RTA, no. RD06/001/001), the Spanish ‘Ministerio de Ciencia e Innovación’ (no. SAF2007-64062), the Spanish ‘Ministerio de Sanidad, Política Social e Igualdad’ (Plan/nNacional Sobre Drogas, no. 2009/026), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008). A.B. was supported by an FI pre-doctoral fellowship of the Catalan Government; J.G.-C. was supported by a ‘Juan de la Cierva’ postdoctoral fellowship from the Spanish ‘Ministerio de Ciencia e Innovación’; and E.M.-G. was supported by a ‘Sara Borrell’ post-doctoral fellowship from the Spanish ‘Instituto de Salud Carlos III’. Partial support from FEDER funds is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour

  • Orejarena Serrano, María-Juliana, 1980-
  • Lanfumey, Laurence
  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing properties. Current evidence indicates that serotonin 5-HT2A receptors (5-HT2ARs) modulate mesolimbic dopamine (DA) activity and several behavioural responses related to the addictive properties of psychostimulants. This study evaluated the role of 5-HT2ARs in MDMA-induced reinforcement and hyperlocomotion, and the reinstatement of MDMA-seeking behaviour. Basal and MDMA-stimulated extracellular levels of DA in the nucleus accumbens (NAc) and serotonin and noradrenaline in the prefrontal cortex were also assessed. Self-administration of MDMA was blunted in 5-HT2AR knockout (KO) mice compared to wild-type (WT) littermates at both doses tested (0.125 and 0.25 mg/kg per infusion). Horizontal locomotion was increased by MDMA (10 and 20 mg/kg i.p.) to a higher extent in KO than in WT mice. DA outflow in the NAc was lower in KO compared to WT mice under basal conditions and after MDMA (20 mg/kg) challenge. In WT mice, MDMA (5 and 10 mg/kg i.p.) priming did not reinstate MDMA-seeking behaviour, while cue-induced reinstatement was prominent. This cue-induced reinstatement was blocked by administration of the selective 5-HT2AR antagonist, SR46349B (eplivanserin) at a dose of 0.5 mg/kg, but not at 0.25 mg/kg. Our results indicate that 5-HT2ARs are crucial for MDMA-induced reinforcement and cue-induced reinstatement of MDMA-seeking behaviour. These effects are probably due to the modulation of mesolimbic dopaminergic activity., This work was supported by the Instituto de Salud Carlos III FIS grant no. PI070709 (to P.R.) and Red de trastornos adictivos (RTA-RETICS) grant no. RD06/001/001 (to R.M.), the Ministerio de Ciencia e Innovación grant no. SAF2007-64062 (to R.M.), the Generalitat de Catalunya grant no. 2009SGR00731 and ICREA Academia award (to R.M.) and the European Commission projects GENADDICT (no. LSHM-CT-2004-05166) and PHECOMP (no. LSHM-CT-037669) (both to R.M.)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate

  • La Porta, Carmen, 1985-
  • Bura, S. Andreea, 1978-
  • Aracil Fernández, Auxiliadora
  • Manzanares, Jorge
  • Maldonado, Rafael, 1961-
Joint pain is a common clinical problem for which both inflammatory and degenerative joint diseases are major causes. The purpose of this study was to investigate the role of CB1 and CB2 cannabinoid receptors in the behavioral, histological, and neurochemical alterations associated with joint pain. The murine model of monosodium iodoacetate (MIA) was used to induce joint pain in knockout mice for CB1 (CB1KO) and CB2 cannabinoid receptors (CB2KO) and transgenic mice overexpressing CB2 receptors (CB2xP). In addition, we evaluated the changes induced by MIA in gene expression of CB1 and CB2 cannabinoid receptors and μ-, δ- and κ-opioid receptors in the lumbar spinal cord of these mice. Wild-type mice, as well as CB1KO, CB2KO, and CB2xP mice, developed mechanical allodynia in the ipsilateral paw after MIA intra-articular injection. CB1KO and CB2KO demonstrated similar levels of mechanical allodynia of that observed in wild-type mice in the ipsilateral paw, whereas allodynia was significantly attenuated in CB2xP. Interestingly, CB2KO displayed a contralateral mirror image of pain developing mechanical allodynia also in the contralateral paw. All mouse lines developed similar histological changes after MIA intra-articular injection. Nevertheless, MIA intra-articular injection produced specific changes in the expression of cannabinoid and opioid receptor genes in lumbar spinal cord sections that were further modulated by the genetic alteration of the cannabinoid receptor system. These results revealed that CB2 receptor plays a predominant role in the control of joint pain manifestations and is involved in the adaptive changes induced in the opioid system under this pain state., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062), “Instituto de Salud Carlos III” (RETICS- Red de Trastornos Adictivos-Redes Temáticas de Investigación Cooperativa en Salud: #RD06/0001/0001, #RD06/0001/1004), Plan Nacional sobre Drogas (PNSD #2009/026), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT, # LSHM-CT-2004-05166, and PHECOMP, # LSHM-CT-2007-037669), CENIT program (CEN-20061005) from/nthe “Centro para el Desarollo Technológico Industrial” from the Spanish Ministry of Science and Innovation. Carmen La Porta (C.L.P) is a recipient of a predoctoral fellowship from the Spanish Ministry of Education. Auxiliadora Aracil-Fernández (A.A.F., predoctoral fellow) and Analía Rico (A.R., technician) are supported by RETICS. The partial support of FEDER funds (EU) is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain

  • Bura, S. Andreea, 1978-
  • Guegan, Thomas, 1983-
  • Zamamillo Castanedo, Daniel
  • Vela Hernández, José Miguel
  • Maldonado, Rafael, 1961-
BACKGROUND: The treatment of neuropathic pain is unsatisfactory at the present moment and the sigma 1 receptor has been identified as a new potential target for neuropathic pain. The aim of this study was to use an operant self-administration model to reveal the potential interest of a new sigma 1 receptor antagonist, S1RA, in chronic pain that was developed in mice by a partial ligation of the sciatic nerve. METHODS: Once that chronic pain had reached a steady state, mice were trained to maintain an operant behaviour to self-administer S1RA. The possible abuse liability of the analgesic compound was determined by evaluating operant self-administration in sham-operated mice. The influence of S1RA on the anhedonic state related to chronic pain was also evaluated by measuring the preference for palatable drink (2% sucrose solution) using a recently validated and highly sensitive behavioural device. RESULTS: Nerve-injured mice, but not sham-operated animals, acquired the operant responding to obtain S1RA (6 mg/kg/infusion). After 10 days of S1RA self-administration, neuropathic pain was significantly reduced in nerve-injured mice. In addition, an anhedonic state was revealed in nerve-injured mice by a decreased consumption of palatable drink, which was significantly attenuated by S1RA (25 mg/kg). CONCLUSIONS: These results reveal the analgesic efficacy of the sigma antagonist, S1RA, in neuropathic pain associated with an improvement of the emotional negative state and that was devoided of reinforcing effects. The operant responses evaluated in this new mouse model can have a high predictive value to estimate the clinical benefit/risk ratio of new analgesic compounds to treat chronic pain, such as S1RA., S1RA was provided by Esteve as a gift within research projects funded by the CENIT program (CEN-20061005) from the Centro para el Desarollo Technológico Industrial from the Spanish Ministry of Science and Innovation (#SAF2007-64062), “Redes temáticas de investigación cooperativa en salud (RETICS) del Instituto de Salud Carlos III (RD06/001/001). Red de trastornos adictivos (RTA)”, the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008) and the DG Research of the European Commission (PHECOMP, #LSHM-CT-2007-037669)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Ayuso, Eduard
  • Santini, Emanuela
  • Fisone, Gilberto
  • Bosch, Fatima
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Palatability enhances food intake by hedonic mechanisms that prevail over caloric necessities. Different studies have demonstrated the role of endogenous cannabinoids in the mesocorticolimbic system in controlling food hedonic value and consumption. We hypothesize that the endogenous cannabinoid system could also be involved in the development of food-induced behavioral alterations, such as food-seeking and binge-eating, by a mechanism that requires neuroplastic changes in the brain reward pathway. For this purpose, we evaluated the role of the CB1 cannabinoid receptor (CB1-R) in the behavioral and neuroplastic changes induced by operant training for standard, highly caloric or highly palatable isocaloric food using different genetics, viral and pharmacological approaches. Neuroplasticity was evaluated by measuring changes in dendritic spine density in neurons previously labeled with the dye DiI. Only operant training to obtain highly palatable isocaloric food induced neuroplastic changes in neurons of the nucleus accumbens shell and prefrontal cortex that were associated to changes in food-seeking behavior. These behavioral and neuroplastic modifications induced by highly palatable isocaloric food were dependent on the activity of the CB1-R. Neuroplastic changes induced by highly palatable isocaloric food are similar to those produced by some drugs of abuse and may be crucial in the alteration of food-seeking behavior leading to overweight and obesity., This work was supported by the Spanish Ministerio de Ciencia e Innovació (#SAF2007-64062 and #SAF2008-00962), the Instituto de Salud CarlosIII (#RD06/001/001), the Plan Nacional sobre Drogas, the Catalan Government (SGR2009-00131 and SGR2009-224), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT,/n#LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the FIS’’ (PI07/0715),ATIP-Avenir and Sanofi-Aventis grants.This work was also supported by the Plan Nacional Sobre Drogas (#2009/026) to R.M.